Explore the full directors' dealings record of Inhibitor Therapeutics, Inc., a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €14.5m. The latest transaction was reported on 10 April 2025 (Attribution). Among the most active insiders: Yanez Michelle. The full history is free.
12
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.